5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-9.81%
Negative net income growth while UPM.HE stands at 17.62%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-8.40%
Negative yoy D&A while UPM.HE is 40.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both cut yoy SBC, with UPM.HE at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-234.57%
Both reduce yoy usage, with UPM.HE at -123.33%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-100.00%
AR is negative yoy while UPM.HE is 100.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-100.00%
Both reduce yoy inventory, with UPM.HE at -100.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-293.48%
Both reduce yoy usage, with UPM.HE at -118.67%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
108.38%
Some yoy increase while UPM.HE is negative at -6.57%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-133.84%
Both yoy CFO lines are negative, with UPM.HE at -12.56%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-147.49%
Negative yoy CapEx while UPM.HE is 28.18%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Purchases growth of 100.00% while UPM.HE is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
98.37%
Growth well above UPM.HE's 34.23%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-0.37%
We reduce yoy invests while UPM.HE stands at 28.43%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-64.88%
Both yoy lines negative, with UPM.HE at -7.32%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.